Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Organ Transplantation ; (6): 106-2023.
Article in Chinese | WPRIM | ID: wpr-959027

ABSTRACT

Objective To analyze clinical prognosis, risk factors and predictive indexes of hyperkalemia in recipients after heart transplantation. Methods Clinical data of 158 recipients were retrospectively analyzed. According to the serum potassium levels within postoperative 1-year follow-up, all recipients were divided into the normal serum potassium level group (n=83), hyperkalemia group (n=43) and severe hyperkalemia group (n=32). The incidence and prognosis of hyperkalemia after heart transplantation were summarized. The risk factors and predictive indexes of hyperkalemia after heart transplantation were identified. Results The incidence of hyperkalemia and severe hyperkalemia within postoperative 1 year was 47.5%(75/158) and 20.3%(32/158), respectively. In the severe hyperkalemia group, the fatality was 16%(5/32), higher than 8%(7/83) in the normal serum potassium level group and 7%(3/43) in the hyperkalemia group. The mean serum creatinine (Scr) within 6 months before heart transplantation, the final total bilirubin level before heart transplantation, postoperative hemodialysis time, the Scr level and N-terminal pro-brain natriuretic peptide level at postoperative 1 d were the independent risk factors for hyperkalemia following heart transplantation (all P < 0.05). The mean Scr level within 6 months before heart transplantation, postoperative hemodialysis time, and Scr levels at postoperative 1 and 7 d could be used to predict postoperative severe hyperkalemia. Conclusions The recipients with severe hyperkalemia after heart transplantation obtain poor prognosis. The mean Scr level within 6 months before heart transplantation, the final total bilirubin level before heart transplantation, postoperative hemodialysis time, and the Scr level and N-terminal pro-brain natriuretic peptide level at postoperative 1 d are the independent risk factors for hyperkalemia after heart transplantation. Perioperative Scr level and postoperative hemodialysis time may be used to predict the incidence of severe hyperkalemia within 1 year after heart transplantation.

2.
Horiz. enferm ; 31(3): 340-357, 2020. tab
Article in Spanish | LILACS, BDENF | ID: biblio-1224102

ABSTRACT

A lo largo de los últimos años la implantación de Dispositivos de Asistencia Ventricular (DAV) está tomando un papel más relevante en el tratamiento de la Insuficiencia Cardíaca (IC). El uso de los DAV también está cambiando hacia la Terapia Definitiva (TD), conformándose como alternativa clara al trasplante cardíaco. La implantación de un DAV, en ocasiones, requiere previamente tratamiento emergente con otros dispositivos de Asistencia Circulatoria Mecánica (ACM) como Circulación Extracorpórea con Membrana de Oxigenación (ECMO) o Asistencia Ventricular paracorpórea Izquierda o Derecha. Por tanto, es necesario el ingreso en Unidades de Cuidados Intensivos (UCI) especializadas en estas terapias hasta la estabilización del paciente y toma de la decisión correcta. Se expone un caso clínico reciente de una persona que requiere asistencia inicial con ECMO V-A emergente en el hospital de origen y su traslado al centro de referencia para posterior asistencia biventricular paracorpórea e implantación definitiva de un DAVI (Dispositivo de Asistencia Ventricular Izquierda). Se exponen la secuencia de decisiones, complicaciones y el plan de cuidados de enfermería inicial en UCI con taxonomía NANDA. Es el primer implante de un DAVI, realizado en nuestro hospital. En él ha intervenido un enorme equipo multidisciplinar.


Over the past few years, the Ventricular Assist Devices (VADs) implementation is taking a relevant role in the Heart Failure (HF) treatment. VADs ́s use is also shifting towards Definitive Therapy (TD), being a clear alternative to heart transplantation. The implantation of a VAD, sometimes, requires a previous emergent treatment with other Mechanical Circulatory Assistance (ACM) devices such as Extracorporeal Circulation with Oxygenation Membrane (ECMO) or Left or Right Paracorporeal Ventricular Assistance. So is necessary of a mobile team for emergency assistance with ECMO and transfer to Intensive Care Units (ICU) which is specialized in these therapies until the patient stabilizes and doctors takes the right decision. A recent clinical case of a patient is exposed. This person required assistance with emergent ECMO V-A (Venous-Arterial) in the hospital of origin and his transfer to the reference center for subsequent biventricular paracorporeal assistance and to the definitive implantation of LVAD (Left Ventricular Assist Device). The sequence of decisions, complications and the initial nursing care plan at ICU with NANDA taxonomy, are presented here. This is the first implant of a LVAD in our hospital. A huge multidisciplinary team has been involved in the project.


Subject(s)
Humans , Male , Adult , Assisted Circulation/methods , Heart-Assist Devices , Heart Failure/drug therapy , Intensive Care Units , Nursing Care , Patient Care Planning , Heart Transplantation/methods , Critical Care
3.
Biomédica (Bogotá) ; 39(supl.2): 11-19, ago. 2019. tab, graf
Article in Spanish | LILACS | ID: biblio-1038823

ABSTRACT

Resumen La miocarditis es una enfermedad inflamatoria del miocardio. Las infecciones virales son la causa más común, aunque también puede deberse a reacciones de hipersensibilidad y de etiología autoinmunitaria, entre otras. El espectro clínico de la enfermedad es variado y comprende desde un curso asintomático, seguido de dolor torácico, arritmias y falla cardiaca aguda, hasta un cuadro fulminante. El término 'fulminante' se refiere al desarrollo de un shock cardiogénico con necesidad de soporte vasopresor e inotrópico o dispositivos de asistencia circulatoria, ya sea oxigenación por membrana extracorpórea o balón de contrapulsación intraaórtico. Cerca del 10 % de los casos de falla cardiaca por miocarditis corresponde a miocarditis fulminante. La miocarditis por influenza se considera una condición infrecuente; no obstante, su incidencia ha aumentado desde el 2009 a raíz de la pandemia de influenza por el virus AH1N1. Por su parte, la miocarditis por influenza de tipo B sigue siendo una condición infrecuente. Se describen aquí dos casos confirmados de miocarditis fulminante por el virus de la influenza B atendidos en un centro cardiovascular, que requirieron dispositivos de asistencia circulatoria mecánica.


Abstract Myocarditis is an inflammatory disease of the myocardium. Viral infections are the most common cause, although it can also be due to hypersensitivity reactions and autoimmune etiology, among other causes. The clinical spectrum of the disease is varied, from an asymptomatic course, followed by chest pain, arrhythmias, and acute heart failure, to a fulminant episode. The term fulminant refers to the development of cardiogenic shock with a need for vasopressor support and inotropic or assisted circulation devices either extracorporeal membrane oxygenation (ECMO) or intra-aortic counterpulsation balloon. About 10% of cases of heart failure due to myocarditis correspond to fulminant myocarditis. Influenza myocarditis has been considered an infrequent condition. However, its incidence has increased since 2009 as a result of the AH1N1 pandemic; otherwise, myocarditis due to the Influenza type B virus remains an infrequent entity. We describe the experience in a cardiovascular center of two confirmed cases of fulminant myocarditis due to influenza B that required circulatory assistance devices.


Subject(s)
Female , Humans , Middle Aged , Young Adult , Influenza B virus , Shock, Cardiogenic/etiology , Influenza, Human/complications , Myocarditis/etiology , Antiviral Agents/therapeutic use , Influenza B virus/isolation & purification , Pericardial Effusion/etiology , Shock, Cardiogenic/drug therapy , Shock, Cardiogenic/therapy , Vasoconstrictor Agents/therapeutic use , Extracorporeal Membrane Oxygenation , Hemofiltration , Fatal Outcome , Combined Modality Therapy , Advanced Cardiac Life Support , Emergencies , Influenza, Human/drug therapy , Influenza, Human/virology , Oseltamivir/therapeutic use , Acute Kidney Injury/etiology , Acute Kidney Injury/therapy , Intra-Aortic Balloon Pumping , Myocarditis/diagnostic imaging
5.
Rev. bras. enferm ; 70(2): 335-341, Mar.-Apr. 2017. tab
Article in English | LILACS, BDENF | ID: biblio-843635

ABSTRACT

ABSTRACT Objective: to develop and validate a nursing care protocol for patients with a ventricular assist device (VAD). Method: descriptive study, with a quantitative approach, for an instrument's methodological validation. Three stages were conducted: development of the instrument; protocol content validation according to the Delphi technique, and agreement among experts and the scientific literature. Results: based on the content validation, a care protocol for patients with a VAD was created and assessed by Spanish experts. Of the 15 items evaluated by means of the content validity index (CVI), 10 presented solid evidence of validation, with Kappa ranging between 0.87 and 1. Conclusion: the method enabled the validation of interventions that will contribute to qualified and standardized care for patients with a VAD.


RESUMEN Objetivo: elaborar y validar un protocolo de atención de enfermería a pacientes con dispositivo de asistencia ventricular (DAV). Método: estudio descriptivo, con abordaje cuantitativo, de validación metodológica de instrumento. Se siguieron tres etapas: elaboración del instrumento; validación del contenido del protocolo según técnica de Delphi y concordancia entre expertos y la literatura científica. Resultados: en base a la validación del contenido, se elaboró un protocolo referido a la atención de pacientes en uso de DAV, evaluado por expertos/jueces españoles. De los 15 ítems evaluados, mediante el índice de Validez de Contenido (IVC), 10 de ellos presentaron fuerte evidencia de validación con Kappa, variando entre 0,87 y 1. Conclusión: el método permitió validar intervenciones que contribuirán a una atención calificada y uniforme a pacientes en uso de DAV.


RESUMO Objetivo: elaborar e validar um protocolo de cuidados de enfermagem a pacientes com dispositivo de assistência ventricular (DAV). Método: estudo descritivo, com abordagem quantitativa de validação metodológica de instrumento. Seguiram-se três etapas: elaboração do instrumento; validação do conteúdo do protocolo segundo a técnica de Delphi e concordância entre peritos e a literatura científica. Resultados: com base na validação do conteúdo, elaborou-se um protocolo referente aos cuidados a paciente em uso de DAV avaliado por peritos/juízes espanhóis. Dos 15 itens avaliados, por meio do Índice de Validade de Conteúdo (IVC), 10 deles apresentaram forte evidência de validação com Kappa que variaram de 0,87 a 1. Conclusão: o método permitiu validar intervenções que contribuirão para um cuidado qualificado e uniformizado a pacientes em uso de DAV.


Subject(s)
Humans , Male , Female , Adult , Reference Standards , Heart-Assist Devices/standards , Practice Guidelines as Topic , Nursing Care/methods , Spain , Surveys and Questionnaires , Delphi Technique , Consensus , Middle Aged
6.
Rev. SOBECC ; 21(1)jan.-mar. 2016. tab
Article in Portuguese | LILACS, BDENF | ID: lil-784422

ABSTRACT

Objetivo: Analisar na literatura científica a prática clínica do enfermeiro ao paciente em uso de assistência circulatória mecânica. Método: Revisão integrativa da literatura realizada nas bases de dados SciELO, Cochrane Library, PubMed e LILACS, de abril a agosto de 2014. Resultados: Embora haja avanço em pesquisas sobre o tema, ainda há poucos estudos, haja vista oito artigos selecionados. Três artigos apontam para a necessidade do enfermeiro deter o conhecimento sobre assistência circulatória mecânica, para uma assistência eficiente e com qualidade. Dois artigos trouxeram a assistência de enfermagem a pacientes em uso de dispositivos. Três relataram complicações devido ao uso do balão intra-aórtico e mostraram que as complicações podem ser minimizadas a partir da capacitação e da avaliação clínica periódica do enfermeiro. Conclusão: Há poucos estudos direcionados à assistência de enfermagem, havendo a necessidade de maior exploração do tema para subsidiar a prática baseada em evidências cientificas.


Objetivo: Analizar en la literatura científica la práctica clínica de las enfermeras a los pacientes utilizándose del soporte circulatorio mecánico. Método: Revisión integradora de la literatura conducida en las bases de datos SciELO, Cochrane Library, PubMed y LILACS, desde abril hasta agosto de 2014. Resultados: Aunque hay avances en la investigación sobre el tema, hay pocos estudios, con solo ocho artículos seleccionados. Tres artículos apuntan a la necesidad de las enfermeras detener los conocimientos sobre soporte circulatorio mecánico para el servicio eficiente y de calidad. Dos artículos presentaron la atención de la enfermería a los pacientes que utilizan dispositivos. Tres estudios informaron complicaciones por la utilización de balón intra-aórtico y mostraron que las complicaciones pueden reducirse al mínimo basándose en la formación y la evaluación clínica periódica de la enfermera. Conclusión: Hay pocos estudios con foco en la atención de la enfermería, y una necesidad de una mayor exploración del tema, para subsidiar la práctica basada en evidencias científicas.


Objective: To analyze in the scientific literature the clinical practice of nurses with patients in use of mechanical circulatory support. Method: Integrative literature review conducted in the databases SciELO, Cochrane Library, PubMed and LILACS, from April to August 2014. Results: Although there is progress in research on the topic, there are few studies, given the eight articles selected. Three articles point to the need for nurses to detain knowledge about mechanical circulatory support for efficient service and quality. Two articles brought the nursing care to patients using devices. Three studies reported complications due to the use of intra-aortic balloon and showed that complications can be minimized through training and periodic clinical assessment of the nurse. Conclusion: There were few articles found, highlighting the need for further exploration of the subject, especially with regard to nursing care.


Subject(s)
Humans , Automation , Intra-Aortic Balloon Pumping , Nursing Care , Review , Ventricular Remodeling , Heart Failure
7.
Arq. bras. cardiol ; 104(1): 78-84, 01/2015. tab, graf
Article in English | LILACS | ID: lil-741129

ABSTRACT

Background: Heart transplantation is considered the gold standard therapy for the advanced heart failure, but donor shortage, especially in pediatric patients, is the main limitation for this procedure, so most sick patients die while waiting for the procedure. Objective: To evaluate the use of short-term circulatory support as a bridge to transplantation in end-stage cardiomyopathy. Methods: Retrospective clinical study. Between January 2011 and December 2013, 40 patients with cardiomyopathy were admitted in our Pediatric Intensive Care Unit, with a mean age of 4.5 years. Twenty patients evolved during hospitalization with clinical deterioration and were classified as Intermacs 1 and 2. One patient died within 24 hours and 19 could be stabilized and were listed. They were divided into 2 groups: A, clinical support alone and B, implantation of short-term circulatory support as bridge to transplantation additionally to clinical therapy. Results: We used short-term mechanical circulatory support as a bridge to transplantation in 9. In group A (n=10), eight died waiting and 2 patients (20%) were transplanted, but none was discharged. In group B (n=9), 6 patients (66.7%) were transplanted and three were discharged.The mean support time was 21,8 days (6 to 984h). The mean transplant waiting list time was 33,8 days. Renal failure and sepsis were the main complication and causeof death in group A while neurologic complications were more prevalent en group B. Conclusion: Mechanical circulatory support increases survival on the pediatric heart transplantation waiting list in patients classified as Intermacs 1 and 2. .


Introdução: O transplante cardíaco é o tratamento de escolha na insuficiência cardíaca terminal, porém a escassez de doadores limita o seu emprego, especialmente na população pediátrica. O implante de dispositivos de assistência circulatória mecânica (ACM) pode aumentar o tempo de espera e contribuir na redução da mortalidade. Objetivo: Estudar a evolução dos pacientes pediátricos com diagnóstico de miocardiopatia, com indicação de transplante e que evoluíram em Intermacs1 ou 2, comparando a utilização ou não de algum tipo de ACM de curta duração. Método: No período de janeiro de 2011 a dezembro de 2013, 40 pacientes com idade média de 4,5 anos foram admitidos com diagnóstico de miocardiopatia dilatada. Desses pacientes, 20 evoluíram em Intermacs 1 ou 2. Um faleceu em menos de 24 horas e 19 foram listados para transplante. Os pacientes foram divididos em dois grupos: A, pacientes manejados clinicamente em espera para o transplante; B, pacientes que utilizaram algum tipo de ACM de curta duração durante o tempo de espera em lista. Resultados: No grupo A (n=10), oito pacientes evoluíram para óbito aguardando o transplante e dois pacientes (20%) foram transplantados, sendo que nenhum recebeu alta hospitalar. No grupo B (n = 9), seis pacientes (66,7%; p = 0,04) foram transplantados e três receberam alta hospitalar (p = 0,049). As principais complicações foram insuficiência renal e sepse, no grupo A, e complicações neurológicas no grupo B. Conclusão: O emprego de ACM de curta duração aumentou a sobrevida dos pacientes priorizados e em fila de espera de transplante cardíaco pediátrico. .


Subject(s)
Child , Child, Preschool , Female , Humans , Infant , Male , Cardiomyopathies/surgery , Heart-Assist Devices , Heart Transplantation/methods , Cardiomyopathies/mortality , Hemodynamics , Hospitalization , Heart Transplantation/mortality , Postoperative Complications , Retrospective Studies , Severity of Illness Index , Time Factors , Treatment Outcome
8.
Acta paul. enferm ; 25(spe1): 13-19, 2012. tab
Article in English | LILACS, BDENF | ID: lil-666727

ABSTRACT

OBJECTIVE: To develop a protocol of care for patients with Intra-Aortic Balloon and validate the content of this protocol. METHODS: Study of quantitative and descriptive approach. The methodology followed three steps: development of the instrument; content validity and reliability verification of the protocol for the analysis of agreement between specialists with greater experience. The study included 48 specialists, including physicians and nurses experienced in patient care in use of balloon. Items considered valid achieved at least 75% of consensus before the analysis of agreement between evaluators. RESULTS: We evaluated 36 items, of these, 20 were considered valid. The reliability was also verified, using consistency of the responses of more experienced evaluators. Among the items submitted to new statistical analysis by these evaluators, only two were considered valid. CONCLUSION: Based on the content validation, a protocol with 22 items concerning patient care without the use of intra-aortic balloon was developed.


OBJETIVOS: Elaborar um protocolo de cuidados a pacientes com Balão Intra Aórtico e validar o conteúdo desse protocolo. MÉTODOS: Estudo de abordagem quantitativa, descritivo. A trajetória metodológica seguiu três etapas: elaboração do instrumento; validação do conteúdo e verificação da confiabilidade do protocolo pela análise de concordância entre peritos com maior tempo de experiência. Participaram do estudo 48 peritos, entre médicos e enfermeiros, experientes em assistência ao paciente em uso do balão. Os itens considerados válidos obtiveram consenso mínimo de 75% perante a análise de concordância entre os avaliadores. RESULTADOS: Foram avaliados 36 itens, destes, 20 foram considerados válidos. Verificou-se também a confiabilidade, utilizando a congruência das respostas dos avaliadores mais experientes. Dos itens submetidos à nova análise estatística por esses avaliadores, apenas dois foram considerados válidos. CONCLUSÃO: Com base na validação do conteúdo, elaborou-se um protocolo com 22 itens referentes aos cuidados a paciente sem uso do Balão Intra-Aórtico.


OBJETIVOS: Elaborar un protocolo de cuidados a pacientes con Balón Intraaórtico y validar el contenido de ese protocolo. MÉTODOS: Estudio de abordaje cuantitativo, descriptivo. La trayectoria metodológica siguió tres etapas: elaboración del instrumento; validación del contenido y verificación de la confiabilidad del protocolo por el análisis de concordancia entre peritos con mayor tiempo de experiencia. Participaron en el estudio 48 peritos, entre médicos y enfermeros, con experiencia en asistencia al paciente en uso del balón. Los items considerados válidos obtuvieron consenso mínimo del 75% frente al análisis de concordancia entre los evaluadores. RESULTADOS: Fueron evaluados 36 items, de éstos, 20 fueron considerados válidos. Se verificó también la confiabilidad, utilizando la congruencia de las respuestas de los evaluadores más experientes. De los items sometidos al nuevo análisis estadístico por esos evaluadores, apenas dos se considerarons válidos. CONCLUSIÓN: Con base en la validación del contenido, se elaboró un protocolo con 22 items referentes a los cuidados al paciente sin uso del Balón Intraaórtico.


Subject(s)
Humans , Patient Care , Intra-Aortic Balloon Pumping , Nursing Care , Validation Studies as Topic , Clinical Protocols , Evaluation Studies as Topic , Epidemiology, Descriptive
9.
Chinese Journal of Organ Transplantation ; (12): 657-660, 2012.
Article in Chinese | WPRIM | ID: wpr-430944

ABSTRACT

Objective To examine the benefits of ECMO for potential organ donors with hemodynamic instability after brain death.Methods Three brain-dead potential donors who presented with hemodynamic instability despite maximal medical management,finished a declaration of brain death,that were supported by extracorporeal circulation membrane oxygenation (ECMO).Results Donor organs,including six kidneys,and two livers,were harvested from the three donors under ECMO support,leading to 8 successful transplantations.The organs functioned well and the recipients made full recoveries.Conclusion Our experience indicates that ECMO allows for the maintenance of abdominal organ tissue perfusion without warm ischemia before organ procurement,providing sufficient time for safe organ donation procedures and reducing the risk of unpredictable cardiac arrest that could result in the donor death and graft loss.

10.
Korean Circulation Journal ; : 402-404, 2011.
Article in English | WPRIM | ID: wpr-85767

ABSTRACT

A 28-year-old male with hemophagocytic lymphohistiocytosis presented with left ventricular dysfunction and cardiac arrest. Percutaneous cardiopulmonary support (PCPS) was initiated, but left heart distension developed with associated aggravation of pulmonary edema. Percutaneous transseptal left atrial sheath (28-Fr) drainage was incorporated into the PCPS venous circuit under fluoroscopic guidance to enable left heart decompression 1 days after PCPS initiation. The patient's pulmonary edema improved markedly, and distention of his left heart diminished. He was successfully weaned from PCPS 5 days later. Percutaneous transseptal left atrial drainage with large venous cannulae is feasible and effective in decompressing the left heart in adult patients during PCPS.


Subject(s)
Adult , Humans , Male , Assisted Circulation , Cardiac Catheterization , Catheters , Decompression , Drainage , Heart , Heart Arrest , Lymphohistiocytosis, Hemophagocytic , Pulmonary Edema , Ventricular Dysfunction, Left
11.
Korean Circulation Journal ; : 1-10, 2009.
Article in English | WPRIM | ID: wpr-22023

ABSTRACT

Mechanical circulatory support is necessary when heart failure becomes refractory to medical support. It is typically instituted when organ dysfunction occurs as a result of hypoperfusion. Enthusiasm has recently developed for the role of mechanical circulatory support in the ever-growing population of heart failure patients. Indeed, efforts in developing this technology have allowed for the relatively recent development of a variety of complete circulatory support devices. The use of left ventricular assist devices (LVADs) in patients with advanced heart failure results in a clinically meaningful survival benefit and an improved quality of life, and LVADs could be an acceptable alternative therapy for selected patients who are not candidates for cardiac transplantation.


Subject(s)
Humans , Assisted Circulation , Heart , Heart Failure , Heart Transplantation , Heart-Assist Devices , Life Support Systems , Quality of Life
12.
Arq. bras. cardiol ; 91(5): 327-334, nov. 2008. ilus, graf, tab
Article in English, Portuguese | LILACS | ID: lil-501812

ABSTRACT

FUNDAMENTO: O transplante cardíaco enfrenta o grave problema da escassez de doadores. Estima-se que entre 20 por cento e 40 por cento dos pacientes falecem na fila de espera. Para esses pacientes, a utilização de dispositivos de assistência circulatória é, muitas vezes, a única possibilidade de sobrevivência durante a espera do doador. No Brasil, não existe nenhum programa regular de utilização desses dispositivos como ponte para transplante. OBJETIVO: Avaliar o desempenho hemodinâmico e a resposta inflamatória durante a utilização do DAV-InCor como ponte para transplante. MÉTODOS: Entre outubro de 2003 e abril de 2006, 11 pacientes, indicados em caráter de prioridade para o transplante cardíaco, evoluíram em choque cardiogênico refratário. O implante do DAV-InCor foi realizado em sete pacientes. O diagnóstico etiológico foi cardiopatia chagásica em cinco pacientes e cardiomiopatia dilatada idiopática em dois. RESULTADOS: A assistência mecânica ao ventrículo esquerdo foi mantida nos sete pacientes por períodos entre 14 e 42 dias (média 26,2). O desempenho hemodinâmico foi adequado, com a normalização do índice cardíaco, dos níveis de saturação venosa de O2 e do lactato. O transplante foi realizado em dois pacientes, os outros cinco faleceram por infecção sistêmica ou falência de múltiplos órgãos. CONCLUSÃO: O desempenho do DAV-Incor, no comportamento hemodinâmico dos pacientes estudados, foi adequado para a manutenção de uma condição circulatória satisfatória durante o período estudado. Houve melhora dos parâmetros de perfusão tecidual e manutenção de sinais de resposta inflamatória sistêmica. Houve alta incidência de complicações; contudo, não foram demonstradas complicações relacionadas ao dispositivo que comprometam a segurança da utilização do mesmo.


BACKGROUND: Cardiac transplantation faces the serious problem of lack of donors and it is estimated that 20 to 40 percent of the patients die while waiting for heart transplantation. For these patients, the use of mechanical circulatory assist devices is the only choice of survival while waiting for a donor. In Brazil, the experience with mechanical circulatory support is limited and there is no regular program regarding the use of these devices as a bridge to heart transplantation. OBJECTIVE: To evaluate the hemodynamic performance and the systemic inflammatory response during the clinical use of the InCor-type ventricular assist device (VAD-InCor) as a bridge to heart transplantation. METHODS: Between October 2003 and April 2006, 11 patients in the waiting list for heart transplantation presented hemodynamic deterioration due to refractory cardiogenic shock. Seven of these patients were submitted to VAD-InCor implantation for left ventricular assistance. The etiologic diagnosis was Chagas' disease in 5 patients and idiopathic dilated cardiomyopathy in 2. RESULTS: The duration of left ventricular assistance ranged from 14 to 42 days (mean 26.2 days). During this period, the hemodynamic performance of the DAV-InCor was adequate to support a normal hemodynamic state. There was normalization of central venous oxygen saturation and serum lactate. Two patients were submitted to heart transplantation, while the other 5 patients died under assistance due to infection and multiple organ failure. CONCLUSION: The performance of the VAD-InCor, in the hemodynamic behavior of the studied patients, was adequate for the maintenance of a satisfactory circulatory state during the studied period. There was improvement in the tissue perfusion parameters and maintenance of systemic inflammatory response signs. There was a high incidence of complications; however, complications related to the device, which could compromise the safety of its use, were not demonstrated.


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Cardiomyopathy, Dilated/physiopathology , Chagas Cardiomyopathy/physiopathology , Heart-Assist Devices , Hemodynamics/physiology , Inflammation Mediators/blood , Biomarkers/blood , C-Reactive Protein/analysis , Cardiomyopathy, Dilated/blood , Cardiomyopathy, Dilated/surgery , Chagas Cardiomyopathy/blood , Chagas Cardiomyopathy/surgery , Heart Transplantation , /blood , /blood , Statistics, Nonparametric , Tumor Necrosis Factor-alpha/blood , Waiting Lists
13.
Chinese Journal of Thoracic and Cardiovascular Surgery ; (12): 252-254, 2008.
Article in Chinese | WPRIM | ID: wpr-382043

ABSTRACT

Objective To investigate the relation between the changes d myocardial collagen content before and after ventricu-lar assist device (LVAD) application and the prognosis in dilated cardiomyopathy. Methods Patients was divided to two groups ac-cording to the prognosis (weaning or transplantation) after LVAD application. Left ventricular samples were collected from the patients (weaning group n= 10, transplanted group n=8) at the time the LVADs were implanted, and again during cardiac transplantation ( n = 8 ). The content of neutral salt soluble collagen (NSC) and acid soluble collagen (ASC) were measured by Sired collagen assay and total collagen and insoluble collagen (ISC) by quantification of hydroxyproline. Moreover, protein quantification of each collagen fraction was performed simultaneously. Results Before LVAD implantation all collagen fraction and their protein contents were higher in the weaning group than that in the transplanted group ( P <0.05), but the difference in the collagen fraction disappeared after LVAD support. Comparison of the pre- and post-LVAD subgroups of the transplanted group showed an increase of NSC and its protein content and total hydroxyproline after LVAD support (P<0.05). Conclusion The significances of myocardial intersititial remodeling in DCM are not identical. Some myocardial collagen and protein content increases may be related to good prognosis. The mechanism of LVAD improving cardiac function may be related to the changes of myocardial intersitial collagen.

15.
Chinese Journal of Emergency Medicine ; (12): 181-184, 2005.
Article in Chinese | WPRIM | ID: wpr-402013

ABSTRACT

Objective To assess the effect of the pulsatile catheter (PUCA) pump support on cardiac resuscitation in sheep,and to provide a new approach for saving cardiac arrest patients. Methods Cardiac arrest was induced by ventricular fibrillation in 11 sheep. These sheep were divided into three groups including no support (n=3), delayed support (n=2) and immediate support (n=6). Time for cardiac resuscitation and the ratio of success to failure in each group were recorded. Hemodynamic parameters including heart rate (HR), cardiac output (CO), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), central venous pressure(CVP),right ventricular end-diastolic pressure (RVEDP),left atrial pressure (LAP), and left ventricular end-diastolic pressure (LVEDP) were monitored and recorded at 5, 60 and 180 min after cardiac resuscitation with PUCA pump. Results Time for cardiac resuscitation in no support group, delayed support group and immediate support group was (38.3±5.8),(43.5±9.2) and (48.7±23.8)minutes, respectively(P>0.05),and the ratio of success to failure was 0/3,0/2 and 5/1, respectively ( P<0.05). After cardiac resuscitation with the PUCA pump support, MAP, SBP and DBP increased gradually(P<0.05).Conclusions PUCA pump can maintain the hemodynamic stability in a sheep model of cardiac arrest,and can thus increase the success rate of cardiac resuscitation. It may be suitable for resuscitating cardiac arrest patients.

16.
The Korean Journal of Thoracic and Cardiovascular Surgery ; : 1003-1009, 2004.
Article in Korean | WPRIM | ID: wpr-158781

ABSTRACT

Mechanical circulatory support (MCS) has been used for myocardium failure, but moreover, it may be essential for the life support in cardiac arrest or cardiogenic shock. Many commercial devices can be used effectively for the long-term support. However, there are some limitations in the aspects of the cost and technical support by production company. Short-term support with centrifugal type has been reported numerously with the purpose of bridging to heart transplantation or recovery. We successfully treated 5 patitents who were in the status of cardiogenic shock (n=3) or arrest (n=2) with the technique of extracorporeal life support system (ECLS) or left ventricular assist device (LVAD) using the centrifugal type pump. The MCS were performed emergently (n=2) under cardiac arrest caused by ischemic heart disease, and urgently (n=3) under cardiogenic shock with ischemic heart disease (n=1) or acute fulminant viral myocarditis (n=2). All patients were weaned from MCS. Complications related to the use of MCS were bleeding and acute renal failure, but there were no major complications related to femoral cannulations. Mechanical circulatory support may be essential for the life support and rescue in cardiac arrest or cardiogenic shock.


Subject(s)
Humans , Acute Kidney Injury , Assisted Circulation , Cardiopulmonary Bypass , Catheterization , Heart Arrest , Heart Transplantation , Heart-Assist Devices , Hemorrhage , Life Support Systems , Myocardial Ischemia , Myocarditis , Myocardium , Shock, Cardiogenic
SELECTION OF CITATIONS
SEARCH DETAIL